Voloridge Investment Management
PDSB icon

Voloridge Investment Management’s PDS Biotechnology PDSB Stock Holding History

Voloridge Investment Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-49,191
Closed -$733K – 1782
2021
Q3 		$733K Buy
49,191
+36,219
+279% +$452K ﹤0.01% 1365
2021
Q2 		$163K Buy
+12,972
New +$101K ﹤0.01% 1571

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voloridge Investment Management's PDSB Position: Q4 2021 in Review

Voloridge Investment Management sold out of PDS Biotechnology (PDSB) in Q4 2021, closing a stake of 49,191 shares — an estimated $733K sold.

Voloridge Investment Management first reported a position in PDSB in Q2 2021 and held it in 2 quarters. The position peaked at $733K in Q3 2021. 65 funds tracked by Wall St. Rank hold PDSB as of Q4 2021.

  • Voloridge Investment Management reported no remaining PDS Biotechnology position as of Q4 2021 after selling out during the quarter.
  • Voloridge Investment Management sold 49,191 PDS Biotechnology shares in Q4 2021, an estimated $733K.
  • Voloridge Investment Management first reported a position in PDS Biotechnology in Q2 2021 and held it in 2 quarters.
  • Voloridge Investment Management's PDS Biotechnology position peaked at $733K in Q3 2021.
  • 65 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2021.

Based on Voloridge Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.